InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| A549-Dual™ Cells | ARF1 prevents aberrant type I interferon induction by regulating STING activa... | 2023 | Nat Commun. | Hirschenberger M. et al. | DOI: 10.1038/s41467-023-42150-4 |
| Jurkat-Raji PD-1/PD-L1 assay (Bio-IC™) | Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverse... | 2023 | Front Immunol. | Mabbitt J. et al. | DOI: 10.3389/fimmu.2023.1250559 |
| PMA - Phorbol myristate acetate | Detection and functional resolution of soluble immune complexes by an FcγR re... | 2023 | EMBO Mol Med. | Chen H. et al. | DOI: 10.15252/emmm.202114182 |
| Ionomycin | Detection and functional resolution of soluble immune complexes by an FcγR re... | 2023 | EMBO Mol Med. | Chen H. et al. | DOI: 10.15252/emmm.202114182 |
| pFUSE-CHIg-hG1 | Imaging Immune Cells Using Fc Domain Probes in Mouse Cancer Xenograft Models. | 2022 | Cancers (Basel). | Bernhard W. et al. | DOI: 10.3390/cancers14020300 |
| Human CD16 Jurkat Reporter Cells for ADCC (NFAT) | Infection pre-Ad26. COV2. S-vaccination primes greater class switching and re... | 2023 | NPJ Vaccines. | Krause R.G.E. et al. | DOI: 10.1038/s41541-023-00724-9 |
| Human CD32 Jurkat Reporter Cells for ADCP (NFAT) | Pathogen-driven degradation of endogenous and therapeutic antibodies during s... | 2023 | Nat Commun. | Toledo A.G. et al. | DOI: 10.1038/s41467-023-42572-0 |
| Human CD16 Jurkat Reporter Cells for ADCC (NFAT) | Pathogen-driven degradation of endogenous and therapeutic antibodies during s... | 2023 | Nat Commun. | Toledo A.G. et al. | DOI: 10.1038/s41467-023-42572-0 |
| QUANTI-Luc™: Luciferase Detection Reagent | Pathogen-driven degradation of endogenous and therapeutic antibodies during s... | 2023 | Nat Commun. | Toledo A.G. et al. | DOI: 10.1038/s41467-023-42572-0 |
| Human CD16 Jurkat Reporter Cells for ADCC (NFAT) | Oral immunization with rVSV bivalent vaccine elicits protective immune respon... | 2023 | Vaccines (Basel) | Ouyang M.J. et al. | DOI: 10.3390/vaccines11091404 |
| QUANTI-Luc™: Luciferase Detection Reagent | Oral immunization with rVSV bivalent vaccine elicits protective immune respon... | 2023 | Vaccines (Basel) | Ouyang M.J. et al. | DOI: 10.3390/vaccines11091404 |
| Human CD16 Jurkat Reporter Cells for ADCC (NFAT) | Despite delayed kinetics, people living with HIV achieve equivalent antibody ... | 2023 | Front Immunol. | Motsoeneng B.M. et al. | DOI: 10.3389/fimmu.2023.1231276 |
| Jurkat Reporter Cells (NFAT) | Brain-restricted mTOR inhibition with binary pharmacology. | 2022 | Nature | Zhang Z. et al. | DOI: 10.1038/s41586-022-05213-y |
| Zeocin® | Brain-restricted mTOR inhibition with binary pharmacology. | 2022 | Nature | Zhang Z. et al. | DOI: 10.1038/s41586-022-05213-y |
| QUANTI-Luc™: Luciferase Detection Reagent | African swine fever virus B175L inhibits the type I interferon pathway by tar... | 2023 | J Virol. | Ranathunga L. et al. | DOI: 10.1128/jvi.00795-23 |
| Blasticidin | African swine fever virus B175L inhibits the type I interferon pathway by tar... | 2023 | J Virol. | Ranathunga L. et al. | DOI: 10.1128/jvi.00795-23 |
| Hygromycin B Gold | African swine fever virus B175L inhibits the type I interferon pathway by tar... | 2023 | J Virol. | Ranathunga L. et al. | DOI: 10.1128/jvi.00795-23 |
| Puromycin | African swine fever virus B175L inhibits the type I interferon pathway by tar... | 2023 | J Virol. | Ranathunga L. et al. | DOI: 10.1128/jvi.00795-23 |
| Zeocin® | African swine fever virus B175L inhibits the type I interferon pathway by tar... | 2023 | J Virol. | Ranathunga L. et al. | DOI: 10.1128/jvi.00795-23 |
| Normocin™ - Antimicrobial Reagent | African swine fever virus B175L inhibits the type I interferon pathway by tar... | 2023 | J Virol. | Ranathunga L. et al. | DOI: 10.1128/jvi.00795-23 |